Meysan Advised Sanam Innovation Holding Company and Arzan Financial Group on the Acquisition of Shares in National Medical Consumable Industries Company (NATMED)

Meysan is pleased to announce its role in advising on a major investment deal involving two prominent market-leading companies—Sanam Innovation Holding Company WLL and Arzan Financial Group for Financing and Investment—as buyers in their acquisition of 75% of NATMED. The transaction, valued at approximately $33 million, marks a significant milestone in the regional investment landscape.

Sanam Innovation Holding Company and Arzan Financial Group, both renowned entities in the financial and investment sectors, have strategically joined forces to acquire a substantial stake in NATMED. This agreement presents a promising opportunity for both investors to expand their portfolios and enhance their market presence in the region.

The deal was meticulously structured and negotiated by Meysan’s team.

Led by Partner Dr. Abdulwahab Sadeq, with the support of Adel AlAsousi and Nour Berbari, the team played a pivotal role in navigating complex negotiations, drafting the necessary legal documents, and ensuring a seamless closing of the transaction.

“We are thrilled to have facilitated this significant transaction between two esteemed clients,” said Dr. Abdulwahab Sadeq. “Our team worked closely with both parties to ensure that their interests were well represented and that the deal progressed smoothly. This agreement opens up exciting new avenues for both purchasers in their ongoing investment strategies.”
Meysan’s commitment to excellence and its client-centric approach were instrumental in securing this highly successful deal. This achievement underscores the firm’s reputation as a leading legal advisor for high-value and strategic transactions across the Middle East and beyond.